πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 400 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8163545

Vaccine against pandemic strains of influenza viruses

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8124109

Vault compositions for immunization against chlamydia genital infection

The Regents of the University of California Β· Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8092812

Methods and compositions for immunization against chlamydial infection and disease

The Board of Regents of the University of Texas System Β· Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8092796

Monoclonal antibodies against ANGPTL4

LEXICON PHARMACEUTICALS, INC. Β· Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8075900

Melanoma associated peptide analogues and vaccines against melanoma

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071084

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071113

Live, oral vaccine for protection against Shigella dysenteriae serotype 1

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8030287

DNA vaccine against North American spring viremia of carp virus

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8017130

Method of accelerated vaccination against Ebola viruses

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7999007

Buffer solutions having selective bactericidal activity against gram negative bacteria and

United Therapeutics Corporation Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7994306

Methods of treating cancer using siRNA molecules directed against CD24

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7988971

Human monoclonal antibodies against Hendra and Nipah viruses

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7951362

Compositions and methods of use of targeting peptides against placenta and adipose tissues

The Board of Regents of the University of Texas System Β· Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7935796

Monoclonal antibodies against ANGPTL3

LEXICON PHARMACEUTICALS, INC. Β· Granted Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7919301

Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of reco

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7914788

Monoclonal antibodies against orthopoxviruses

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7892567

Methods and compositions for immunization against chlamydial infection and disease

The Board of Regents of the University of Texas System Β· Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7883710

Peptide vaccines against Group A streptococci

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7871986

Methods of stimulating an immune response against prostate specific antigen

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7872110

Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV

United Biomedical, Inc. Β· Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7867983

Methods to protect skeletal muscle against injury

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7862821

Recombinant vaccine against bluetongue virus

The Regents of the University of California Β· Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7858592

Interfering RNAs against the promoter region of P53

The Board of Regents of the University of Texas System Β· Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7846450

Melanoma associated peptide analogues and vaccines against melanoma

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted